Report Summary
Eternity Insights has published a new study on Global Erectile Dysfunction Devices Market focusing on key segments as by Type (ED Drugs, ED Devices, Other), by Application (Congenital Patients, Pathological Patients, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Erectile Dysfunction Devices Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Erectile Dysfunction Devices Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Erectile Dysfunction Devices Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Erectile Dysfunction Devices Market Segmentation:
Erectile Dysfunction Devices Market, By Type
- ED Drugs
- ED Devices
- Other
Erectile Dysfunction Devices Market, By Application
- Congenital Patients
- Pathological Patients
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Erectile Dysfunction Devices market in terms of demand generation. The Erectile Dysfunction Devices market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Erectile Dysfunction Devices market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Erectile Dysfunction Devices Market Taxonomy:
To learn more about this report
Global Erectile Dysfunction Devices Market Competitive Landscape
The global Erectile Dysfunction Devices market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Eli Lilly
- Pfizer
- Bayer
- Boston Scientific
- Coloplast
- Apricus Biosciences
- Cristalia Produtos Quimicos Farmaceuticos
- Dong-A Socio
- Endo Pharmaceuticals
- Futura Medical
- Meda Pharmaceuticals
- Promedon
- SK Chemical
- Teva Pharmaceuticals
- Vivus
- Zephyr Surgical Implants (ZSI)
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
ED Drugs, ED Devices, Other |
| By Application Outlook |
Congenital Patients, Pathological Patients, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Eli Lilly, Pfizer, Bayer, Boston Scientific, Coloplast, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Meda Pharmaceuticals, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, Zephyr Surgical Implants (ZSI) |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Erectile Dysfunction Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Erectile Dysfunction Devices Market Size Growth Rate by Product
1.4.2 Inflatable Penile Implant
1.4.3 Semi-Rigid Rod Implant
1.5 Market by End User
1.5.1 Global Erectile Dysfunction Devices Market Size Growth Rate by End User
1.5.2 Congenital Patients
1.5.3 Pathological Patients
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Devices Market Size
2.1.1 Global Erectile Dysfunction Devices Revenue 2017-2027
2.1.2 Global Erectile Dysfunction Devices Sales 2017-2027
2.2 Erectile Dysfunction Devices Growth Rate by Regions
2.2.1 Global Erectile Dysfunction Devices Sales by Regions
2.2.2 Global Erectile Dysfunction Devices Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Erectile Dysfunction Devices Sales by Manufacturers
3.1.1 Erectile Dysfunction Devices Sales by Manufacturers
3.1.2 Erectile Dysfunction Devices Sales Market Share by Manufacturers
3.1.3 Global Erectile Dysfunction Devices Market Concentration Ratio (CR5 and HHI)
3.2 Erectile Dysfunction Devices Revenue by Manufacturers
3.2.1 Erectile Dysfunction Devices Revenue by Manufacturers (2017-2020)
3.2.2 Erectile Dysfunction Devices Revenue Share by Manufacturers (2017-2020)
3.3 Erectile Dysfunction Devices Price by Manufacturers
3.4 Erectile Dysfunction Devices Manufacturing Base Distribution, Product Types
3.4.1 Erectile Dysfunction Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erectile Dysfunction Devices Product Type
3.4.3 Date of International Manufacturers Enter into Erectile Dysfunction Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Erectile Dysfunction Devices Sales by Product
4.2 Global Erectile Dysfunction Devices Revenue by Product
4.3 Erectile Dysfunction Devices Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Erectile Dysfunction Devices Breakdown Data by End User
6 North America
6.1 North America Erectile Dysfunction Devices by Countries
6.1.1 North America Erectile Dysfunction Devices Sales by Countries
6.1.2 North America Erectile Dysfunction Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Erectile Dysfunction Devices by Product
6.3 North America Erectile Dysfunction Devices by End User
7 Europe
7.1 Europe Erectile Dysfunction Devices by Countries
7.1.1 Europe Erectile Dysfunction Devices Sales by Countries
7.1.2 Europe Erectile Dysfunction Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Erectile Dysfunction Devices by Product
7.3 Europe Erectile Dysfunction Devices by End User
8 Asia Pacific
8.1 Asia Pacific Erectile Dysfunction Devices by Countries
8.1.1 Asia Pacific Erectile Dysfunction Devices Sales by Countries
8.1.2 Asia Pacific Erectile Dysfunction Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Erectile Dysfunction Devices by Product
8.3 Asia Pacific Erectile Dysfunction Devices by End User
9 Central & South America
9.1 Central & South America Erectile Dysfunction Devices by Countries
9.1.1 Central & South America Erectile Dysfunction Devices Sales by Countries
9.1.2 Central & South America Erectile Dysfunction Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Erectile Dysfunction Devices by Product
9.3 Central & South America Erectile Dysfunction Devices by End User
10 Middle East and Africa
10.1 Middle East and Africa Erectile Dysfunction Devices by Countries
10.1.1 Middle East and Africa Erectile Dysfunction Devices Sales by Countries
10.1.2 Middle East and Africa Erectile Dysfunction Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Erectile Dysfunction Devices by Product
10.3 Middle East and Africa Erectile Dysfunction Devices by End User
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Company Business Overview
11.1.3 Eli Lilly Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Eli Lilly Erectile Dysfunction Devices Products Offered
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Pfizer Erectile Dysfunction Devices Products Offered
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Bayer Erectile Dysfunction Devices Products Offered
11.3.5 Bayer Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Company Business Overview
11.4.3 Boston Scientific Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Boston Scientific Erectile Dysfunction Devices Products Offered
11.4.5 Boston Scientific Recent Development
11.5 Coloplast
11.5.1 Coloplast Company Details
11.5.2 Company Business Overview
11.5.3 Coloplast Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Coloplast Erectile Dysfunction Devices Products Offered
11.5.5 Coloplast Recent Development
11.6 Apricus Biosciences
11.6.1 Apricus Biosciences Company Details
11.6.2 Company Business Overview
11.6.3 Apricus Biosciences Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Apricus Biosciences Erectile Dysfunction Devices Products Offered
11.6.5 Apricus Biosciences Recent Development
11.7 Cristalia Produtos Quimicos Farmaceuticos
11.7.1 Cristalia Produtos Quimicos Farmaceuticos Company Details
11.7.2 Company Business Overview
11.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Devices Products Offered
11.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Development
11.8 Dong-A Socio
11.8.1 Dong-A Socio Company Details
11.8.2 Company Business Overview
11.8.3 Dong-A Socio Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Dong-A Socio Erectile Dysfunction Devices Products Offered
11.8.5 Dong-A Socio Recent Development
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Endo Pharmaceuticals Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Endo Pharmaceuticals Erectile Dysfunction Devices Products Offered
11.9.5 Endo Pharmaceuticals Recent Development
11.10 Futura Medical
11.10.1 Futura Medical Company Details
11.10.2 Company Business Overview
11.10.3 Futura Medical Erectile Dysfunction Devices Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Futura Medical Erectile Dysfunction Devices Products Offered
11.10.5 Futura Medical Recent Development
11.11 Meda Pharmaceuticals
11.12 Promedon
11.13 SK Chemical
11.14 Teva Pharmaceuticals
11.15 Vivus
11.16 Zephyr Surgical Implants (ZSI)
12 Future Forecast
12.1 Erectile Dysfunction Devices Market Forecast by Regions
12.1.1 Global Erectile Dysfunction Devices Sales Forecast by Regions 2019-2025
12.1.2 Global Erectile Dysfunction Devices Revenue Forecast by Regions 2019-2025
12.2 Erectile Dysfunction Devices Market Forecast by Product
12.2.1 Global Erectile Dysfunction Devices Sales Forecast by Product 2019-2025
12.2.2 Global Erectile Dysfunction Devices Revenue Forecast by Product 2019-2025
12.3 Erectile Dysfunction Devices Market Forecast by End User
12.4 North America Erectile Dysfunction Devices Forecast
12.5 Europe Erectile Dysfunction Devices Forecast
12.6 Asia Pacific Erectile Dysfunction Devices Forecast
12.7 Central & South America Erectile Dysfunction Devices Forecast
12.8 Middle East and Africa Erectile Dysfunction Devices Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Erectile Dysfunction Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
